These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26951010)

  • 1. [Characterization of Serial Passage of 1b/2a Chimera Hepatitis C Virus Cell Culture System Carrying Envelope E1E2 Coding Gene from Hebei Strain of China].
    Lu S; Zhang L; Tao G; Cai M; Bao Lili ; LI L; Deng Y; Shen X; Tan W
    Bing Du Xue Bao; 2015 Nov; 31(6):647-52. PubMed ID: 26951010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
    Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
    Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.
    Wasilewski LN; Ray SC; Bailey JR
    J Gen Virol; 2016 Nov; 97(11):2883-2893. PubMed ID: 27667373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of infectious pseudo-particle harboring three subtypes hepatitis C virus glycoproteins and their application in neutralization assays].
    Zhang K; Tan WJ; Deng Y; Li J; Wu XB; Ruan L
    Bing Du Xue Bao; 2008 Jul; 24(4):287-94. PubMed ID: 18780632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
    Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
    Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
    Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
    Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
    McCaffrey K; Gouklani H; Boo I; Poumbourios P; Drummer HE
    J Gen Virol; 2011 Jan; 92(Pt 1):112-21. PubMed ID: 20926639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.
    Cai W; Su L; Liao Q; Ye L; Wu Y; Wu Z; She Y
    Antiviral Res; 2010 Oct; 88(1):80-5. PubMed ID: 20691736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and recovery of chimeric rabies virus expressing envelop proteins E1E2 of hepatitis C].
    Du JL; Huang Y; Tang Q; Wang LH; Liang GD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):170-2. PubMed ID: 21977582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations.
    Mori KI; Matsumoto A; Maki N; Ichikawa Y; Tanaka E; Yagi S
    BMC Microbiol; 2016 Sep; 16(1):224. PubMed ID: 27678340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
    Kachko A; Kochneva G; Sivolobova G; Grazhdantseva A; Lupan T; Zubkova I; Wells F; Merchlinsky M; Williams O; Watanabe H; Ivanova A; Shvalov A; Loktev V; Netesov S; Major ME
    Vaccine; 2011 Dec; 30(1):69-77. PubMed ID: 22041300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
    Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
    Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains.
    Lin X; Zhang Y; Bi S; Lu J; Zhao H; Tan W; Li D; Wang Y
    Biochem Biophys Res Commun; 2009 Jul; 385(2):257-62. PubMed ID: 19464265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice.
    Kimura T; Imamura M; Hiraga N; Hatakeyama T; Miki D; Noguchi C; Mori N; Tsuge M; Takahashi S; Fujimoto Y; Iwao E; Ochi H; Abe H; Maekawa T; Arataki K; Tateno C; Yoshizato K; Wakita T; Okamoto T; Matsuura Y; Chayama K
    J Gen Virol; 2008 Sep; 89(Pt 9):2108-2113. PubMed ID: 18753219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
    Hiraga N; Imamura M; Tsuge M; Noguchi C; Takahashi S; Iwao E; Fujimoto Y; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Sakai A; Sakai Y; Honda M; Kaneko S; Wakita T; Chayama K
    FEBS Lett; 2007 May; 581(10):1983-7. PubMed ID: 17466983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction and functional characterization of a monocistronic replicon based on the HCV genotype 2a promotor].
    Li XL; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):103-7. PubMed ID: 22464780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b.
    Murakami K; Ishii K; Ishihara Y; Yoshizaki S; Tanaka K; Gotoh Y; Aizaki H; Kohara M; Yoshioka H; Mori Y; Manabe N; Shoji I; Sata T; Bartenschlager R; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2006 Aug; 351(2):381-92. PubMed ID: 16678876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
    Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
    Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.